Work

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice

Year: 2013

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-013-2700-1

Authors: Kathryn J. Ruddy, Stephen D. Desantis, Rebecca S. Gelman, Alan H. B. Wu, Rinaa S. Punglia, Erica L. Mayer, Sara M. Tolaney, Eric P. Winer, Ann H. Partridge, Harold J. Burstein

Institutions: Dana-Farber Cancer Institute, San Francisco General Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2060662500

FWCI: 4.578

Cites: 19

Cited by: 29

Related to: 10